Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cibus to Present at the H.C. Wainwright 25th Annual Global Investment Conference By: Cibus US LLC via GlobeNewswire September 05, 2023 at 08:00 AM EDT SAN DIEGO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced that Rory Riggs, Co-Founder, Chief Executive Officer, and Chairman, will present at H.C. Wainwright 25th Annual Global Investment Conference taking place September 11-13, 2023. The presentation details are as follows: Presentation detailsDate: Monday, September 11, 2023Presentation Time: 9:30 – 10:00 AM ETWebcast: https://journey.ct.events/view/1713f8d9-cf06-4068-b16a-525a8ce2b884 A webcast of the corporate presentation will be available for viewing and replay on the Investors section of Cibus’ website at www.cibus.com. Management is also available for 1:1 meetings during the conference. Conference attendees should reach out to event organizers or ktroeber@cibus.com to schedule. About Cibus Cibus is part of the multi-billion-dollar plant seed industry. Cibus is the leader in the new era of high-throughput gene editing technology that can develop plant traits precisely and predictably at a fraction of the time and cost of conventional breeding. Cibus is not a seed company. It is a technology company that develops and licenses traits to seed companies in exchange for royalties on seed sales. Cibus’ target market is productivity traits that improve yields, lower input costs such as chemicals, and increase the sustainability and profitability of farming. It has a pipeline of six productivity traits including important traits for pod shatter reduction, disease resistance, and nitrogen-use efficiency. Cibus’ focus is scale, multi-crop traits that can impact greater than 100 MM acres. CIBUS CONTACTS: INVESTOR RELATIONSKaren Troeberktroeber@cibus.com858-450-2636 MEDIA RELATIONSTheodore Lowentlowen@cibus.com914-343-6794 Colin Sanfordcolin@bioscribe.com203-918-4347 Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Cibus to Present at the H.C. Wainwright 25th Annual Global Investment Conference By: Cibus US LLC via GlobeNewswire September 05, 2023 at 08:00 AM EDT SAN DIEGO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced that Rory Riggs, Co-Founder, Chief Executive Officer, and Chairman, will present at H.C. Wainwright 25th Annual Global Investment Conference taking place September 11-13, 2023. The presentation details are as follows: Presentation detailsDate: Monday, September 11, 2023Presentation Time: 9:30 – 10:00 AM ETWebcast: https://journey.ct.events/view/1713f8d9-cf06-4068-b16a-525a8ce2b884 A webcast of the corporate presentation will be available for viewing and replay on the Investors section of Cibus’ website at www.cibus.com. Management is also available for 1:1 meetings during the conference. Conference attendees should reach out to event organizers or ktroeber@cibus.com to schedule. About Cibus Cibus is part of the multi-billion-dollar plant seed industry. Cibus is the leader in the new era of high-throughput gene editing technology that can develop plant traits precisely and predictably at a fraction of the time and cost of conventional breeding. Cibus is not a seed company. It is a technology company that develops and licenses traits to seed companies in exchange for royalties on seed sales. Cibus’ target market is productivity traits that improve yields, lower input costs such as chemicals, and increase the sustainability and profitability of farming. It has a pipeline of six productivity traits including important traits for pod shatter reduction, disease resistance, and nitrogen-use efficiency. Cibus’ focus is scale, multi-crop traits that can impact greater than 100 MM acres. CIBUS CONTACTS: INVESTOR RELATIONSKaren Troeberktroeber@cibus.com858-450-2636 MEDIA RELATIONSTheodore Lowentlowen@cibus.com914-343-6794 Colin Sanfordcolin@bioscribe.com203-918-4347
SAN DIEGO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced that Rory Riggs, Co-Founder, Chief Executive Officer, and Chairman, will present at H.C. Wainwright 25th Annual Global Investment Conference taking place September 11-13, 2023. The presentation details are as follows: Presentation detailsDate: Monday, September 11, 2023Presentation Time: 9:30 – 10:00 AM ETWebcast: https://journey.ct.events/view/1713f8d9-cf06-4068-b16a-525a8ce2b884 A webcast of the corporate presentation will be available for viewing and replay on the Investors section of Cibus’ website at www.cibus.com. Management is also available for 1:1 meetings during the conference. Conference attendees should reach out to event organizers or ktroeber@cibus.com to schedule. About Cibus Cibus is part of the multi-billion-dollar plant seed industry. Cibus is the leader in the new era of high-throughput gene editing technology that can develop plant traits precisely and predictably at a fraction of the time and cost of conventional breeding. Cibus is not a seed company. It is a technology company that develops and licenses traits to seed companies in exchange for royalties on seed sales. Cibus’ target market is productivity traits that improve yields, lower input costs such as chemicals, and increase the sustainability and profitability of farming. It has a pipeline of six productivity traits including important traits for pod shatter reduction, disease resistance, and nitrogen-use efficiency. Cibus’ focus is scale, multi-crop traits that can impact greater than 100 MM acres. CIBUS CONTACTS: INVESTOR RELATIONSKaren Troeberktroeber@cibus.com858-450-2636 MEDIA RELATIONSTheodore Lowentlowen@cibus.com914-343-6794 Colin Sanfordcolin@bioscribe.com203-918-4347